Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: ASTRAZENECA CANADA INC
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Cancelled Post Market | 02236606 | ASTRAZENECA CANADA INC | ACCOLATE TAB 20 MG | Human | Yes | Prescription | 1 | ZAFIRLUKAST | 20 MG |
| Marketed | 02224135 | ASTRAZENECA CANADA INC | ARIMIDEX | Human | Yes | Prescription | 1 | ANASTROZOLE | 1 MG |
| Marketed | 02239090 | ASTRAZENECA CANADA INC | ATACAND | Human | Yes | Prescription | 1 | CANDESARTAN CILEXETIL | 4 MG |
| Marketed | 02239091 | ASTRAZENECA CANADA INC | ATACAND | Human | Yes | Prescription | 1 | CANDESARTAN CILEXETIL | 8 MG |
| Marketed | 02239092 | ASTRAZENECA CANADA INC | ATACAND | Human | Yes | Prescription | 1 | CANDESARTAN CILEXETIL | 16 MG |
| Marketed | 02311658 | ASTRAZENECA CANADA INC | ATACAND | Human | Yes | Prescription | 1 | CANDESARTAN CILEXETIL | 32 MG |
| Marketed | 02244021 | ASTRAZENECA CANADA INC | ATACAND PLUS | Human | Yes | Prescription | 2 | CANDESARTAN CILEXETIL | 16 MG |
| Marketed | 02332922 | ASTRAZENECA CANADA INC | ATACAND PLUS | Human | Yes | Prescription | 2 | CANDESARTAN CILEXETIL | 32 MG |
| Marketed | 02332957 | ASTRAZENECA CANADA INC | ATACAND PLUS | Human | Yes | Prescription | 2 | CANDESARTAN CILEXETIL | 32 MG |
| Cancelled Post Market | 00497827 | ASTRAZENECA CANADA INC | BETALOC DURULES TAB 200 MG | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 200 MG / SRT |
| Cancelled Post Market | 00719846 | ASTRAZENECA CANADA INC | BETALOC IV INJ 1 MG/ML | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 1 MG / ML |
| Cancelled Post Market | 00402540 | ASTRAZENECA CANADA INC | BETALOC TAB 100 MG | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 100 MG |
| Cancelled Post Market | 00402605 | ASTRAZENECA CANADA INC | BETALOC TAB 50 MG | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 50 MG |
| Cancelled Post Market | 00249580 | ASTRAZENECA CANADA INC | BIQUIN DURULES 250 MG | Human | No | Ethical | 1 | QUINIDINE ACID SULFATE | 250 MG |
| Marketed | 02518058 | ASTRAZENECA CANADA INC | BREZTRI AEROSPHERE | Human | Yes | Prescription | 3 | BUDESONIDE | 160 MCG / ACT |
| Cancelled Post Market | 00335355 | ASTRAZENECA CANADA INC | BRICANYL TAB 2.5 MG | Human | No | Prescription | 1 | TERBUTALINE SULFATE | 2.5 MG |
| Cancelled Post Market | 00335363 | ASTRAZENECA CANADA INC | BRICANYL TAB 5 MG | Human | No | Prescription | 1 | TERBUTALINE SULFATE | 5 MG |
| Marketed | 00786616 | ASTRAZENECA CANADA INC | BRICANYL TURBUHALER | Human | Yes | Prescription | 1 | TERBUTALINE SULFATE | 0.5 MG / ACT |
| Marketed | 02368544 | ASTRAZENECA CANADA INC | BRILINTA | Human | Yes | Prescription | 1 | TICAGRELOR | 90 MG |
| Marketed | 02455005 | ASTRAZENECA CANADA INC | BRILINTA | Human | Yes | Prescription | 1 | TICAGRELOR | 60 MG |
| Cancelled Post Market | 02448610 | ASTRAZENECA CANADA INC | BYDUREON | Human | Yes | Prescription | 1 | EXENATIDE | 2 MG / DOSE |
| Cancelled Pre Market | 02483203 | ASTRAZENECA CANADA INC | BYDUREON BCISE | Human | Yes | Prescription | 1 | EXENATIDE | 2 MG / DOSE |
| Cancelled Post Market | 02361809 | ASTRAZENECA CANADA INC | BYETTA | Human | Yes | Prescription | 1 | EXENATIDE | 5 MCG / ACT |
| Cancelled Post Market | 02361817 | ASTRAZENECA CANADA INC | BYETTA | Human | Yes | Prescription | 1 | EXENATIDE | 10 MCG / ACT |
| Cancelled Post Market | 00705527 | ASTRAZENECA CANADA INC | CALCIUM CHLORIDE INJECTION 100MG/ML | Human | No | Ethical | 1 | CALCIUM CHLORIDE | 100 MG / ML |
| Cancelled Post Market | 00707813 | ASTRAZENECA CANADA INC | CALCIUM GLUCONATE 10% INJ 100MG/ML | Human | No | Ethical | 1 | CALCIUM GLUCONATE | 100 MG / ML |
| Marketed | 02491788 | ASTRAZENECA CANADA INC | CALQUENCE | Human | Yes | Prescription | 1 | ACALABRUTINIB | 100 MG |
| Marketed | 02535696 | ASTRAZENECA CANADA INC | CALQUENCE | Human | Yes | Prescription | 1 | ACALABRUTINIB (ACALABRUTINIB MALEATE) | 100 MG |
| Cancelled Pre Market | 02231762 | ASTRAZENECA CANADA INC | CARDURA-1,2,AND 4 | Human | Yes | Prescription | 3 | DOXAZOSIN (DOXAZOSIN MESYLATE) | 4 MG |
| Marketed | 02184478 | ASTRAZENECA CANADA INC | CASODEX | Human | Yes | Prescription | 1 | BICALUTAMIDE | 50 MG |
| Marketed | 02247162 | ASTRAZENECA CANADA INC | CRESTOR - 10MG | Human | Yes | Prescription | 1 | ROSUVASTATIN (ROSUVASTATIN CALCIUM) | 10 MG |
| Marketed | 02247163 | ASTRAZENECA CANADA INC | CRESTOR - 20MG | Human | Yes | Prescription | 1 | ROSUVASTATIN (ROSUVASTATIN CALCIUM) | 20 MG |
| Marketed | 02247164 | ASTRAZENECA CANADA INC | CRESTOR - 40MG | Human | Yes | Prescription | 1 | ROSUVASTATIN (ROSUVASTATIN CALCIUM) | 40 MG |
| Marketed | 02265540 | ASTRAZENECA CANADA INC | CRESTOR - 5MG | Human | Yes | Prescription | 1 | ROSUVASTATIN (ROSUVASTATIN CALCIUM) | 5 MG |
| Marketed | 02359456 | ASTRAZENECA CANADA INC | DAXAS | Human | Yes | Prescription | 1 | ROFLUMILAST | 500 MCG |
| Cancelled Post Market | 00705519 | ASTRAZENECA CANADA INC | DIMENHYDRINATE INJECTION 50MG/ML | Human | No | Ethical | 1 | DIMENHYDRINATE | 50 MG / ML |
| Marketed | 02514400 | ASTRAZENECA CANADA INC | ENHERTU | Human | Yes | Prescription | 1 | TRASTUZUMAB DERUXTECAN | 100 MG / VIAL |
| Marketed | 02514400 | ASTRAZENECA CANADA INC | ENHERTU | Human | Yes | Schedule D | 1 | TRASTUZUMAB DERUXTECAN | 100 MG / VIAL |
| Cancelled Post Market | 02526271 | ASTRAZENECA CANADA INC | EVUSHELD | Human | Yes | Schedule D | 2 | TIXAGEVIMAB | 150 MG / 1.5 ML |
| Cancelled Post Market | 02526271 | ASTRAZENECA CANADA INC | EVUSHELD | Human | Yes | Prescription | 2 | TIXAGEVIMAB | 150 MG / 1.5 ML |
| Marketed | 02473232 | ASTRAZENECA CANADA INC | FASENRA | Human | Yes | Schedule D | 1 | BENRALIZUMAB | 30 MG / ML |
| Marketed | 02473232 | ASTRAZENECA CANADA INC | FASENRA | Human | Yes | Prescription | 1 | BENRALIZUMAB | 30 MG / ML |
| Marketed | 02496135 | ASTRAZENECA CANADA INC | FASENRA PEN | Human | Yes | Prescription | 1 | BENRALIZUMAB | 30 MG / ML |
| Marketed | 02496135 | ASTRAZENECA CANADA INC | FASENRA PEN | Human | Yes | Schedule D | 1 | BENRALIZUMAB | 30 MG / ML |
| Marketed | 02248624 | ASTRAZENECA CANADA INC | FASLODEX | Human | Yes | Prescription | 1 | FULVESTRANT | 50 MG / ML |
| Cancelled Post Market | 02352621 | ASTRAZENECA CANADA INC | FLUMIST | Human | Yes | Schedule D | 3 | INFLUENZA VIRUS TYPE A (H1N1) | 10000000 FFU / 0.2 ML |
| Marketed | 02426544 | ASTRAZENECA CANADA INC | FLUMIST QUADRIVALENT | Human | Yes | Schedule D | 4 | INFLUENZA VIRUS TYPE A (H1N1) | 32000000 FFU / 0.2 ML |
| Marketed | 02435462 | ASTRAZENECA CANADA INC | FORXIGA | Human | Yes | Prescription | 1 | DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) | 5 MG |
| Marketed | 02435470 | ASTRAZENECA CANADA INC | FORXIGA | Human | Yes | Prescription | 1 | DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) | 10 MG |
| Approved | 02473615 | ASTRAZENECA CANADA INC | GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION | Human | Yes | Prescription | 2 | GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) | 8.3 MCG / ACT |
| Marketed | 02468816 | ASTRAZENECA CANADA INC | IMFINZI | Human | Yes | Prescription | 1 | DURVALUMAB | 50 MG / ML |
| Marketed | 02468816 | ASTRAZENECA CANADA INC | IMFINZI | Human | Yes | Schedule D | 1 | DURVALUMAB | 50 MG / ML |
| Marketed | 02541009 | ASTRAZENECA CANADA INC | IMJUDO | Human | Yes | Prescription | 1 | TREMELIMUMAB | 20 MG / ML |
| Marketed | 02248676 | ASTRAZENECA CANADA INC | IRESSA | Human | Yes | Prescription | 1 | GEFITINIB | 250 MG |
| Cancelled Post Market | 00001910 | ASTRAZENECA CANADA INC | JECTOFER 50 MG/ML | Human | No | Prescription | 1 | IRON SORBITEX | 100 MG / AMP |
| Marketed | 02389169 | ASTRAZENECA CANADA INC | KOMBOGLYZE | Human | Yes | Prescription | 2 | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) | 2.5 MG |
| Marketed | 02389177 | ASTRAZENECA CANADA INC | KOMBOGLYZE | Human | Yes | Prescription | 2 | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) | 2.5 MG |
| Marketed | 02389185 | ASTRAZENECA CANADA INC | KOMBOGLYZE | Human | Yes | Prescription | 2 | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) | 2.5 MG |
| Marketed | 02490714 | ASTRAZENECA CANADA INC | LOKELMA | Human | Yes | Prescription | 1 | SODIUM ZIRCONIUM CYCLOSILICATE | 5 G / SACHET |
| Marketed | 02490722 | ASTRAZENECA CANADA INC | LOKELMA | Human | Yes | Prescription | 1 | SODIUM ZIRCONIUM CYCLOSILICATE | 10 G / SACHET |
| Cancelled Post Market | 02230737 | ASTRAZENECA CANADA INC | LOSEC 10 MG | Human | Yes | Prescription | 1 | OMEPRAZOLE (OMEPRAZOLE MAGNESIUM) | 10 MG |
| Cancelled Post Market | 02119579 | ASTRAZENECA CANADA INC | LOSEC CAPSULES 10MG | Human | Yes | Prescription | 1 | OMEPRAZOLE | 10 MG |
| Cancelled Post Market | 02016788 | ASTRAZENECA CANADA INC | LOSEC CAPSULES 40MG | Human | Yes | Prescription | 1 | OMEPRAZOLE | 40 MG |
| Cancelled Post Market | 02454408 | ASTRAZENECA CANADA INC | LYNPARZA | Human | Yes | Prescription | 1 | OLAPARIB | 50 MG |
| Marketed | 02475200 | ASTRAZENECA CANADA INC | LYNPARZA | Human | Yes | Prescription | 1 | OLAPARIB | 100 MG |
| Marketed | 02475219 | ASTRAZENECA CANADA INC | LYNPARZA | Human | Yes | Prescription | 1 | OLAPARIB | 150 MG |
| Cancelled Post Market | 02229416 | ASTRAZENECA CANADA INC | NAROPIN INJ 7.5MG/ML | Human | No | Ethical | 1 | ROPIVACAINE HYDROCHLORIDE | 7.5 MG / ML |
| Cancelled Post Market | 00613304 | ASTRAZENECA CANADA INC | NESACAINE CE 2% INJ 20MG/ML | Human | Yes | Ethical | 1 | CHLOROPROCAINE HYDROCHLORIDE | 20 MG / ML |
| Cancelled Post Market | 00613312 | ASTRAZENECA CANADA INC | NESACAINE CE 3% INJ 30MG/ML | Human | No | Ethical | 1 | CHLOROPROCAINE HYDROCHLORIDE | 30 MG / ML |
| Marketed | 02300524 | ASTRAZENECA CANADA INC | NEXIUM | Human | Yes | Prescription | 1 | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) | 10 MG / SACHET |
| Marketed | 02244521 | ASTRAZENECA CANADA INC | NEXIUM - 20MG | Human | Yes | Prescription | 1 | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) | 20 MG |
| Marketed | 02244522 | ASTRAZENECA CANADA INC | NEXIUM - 40MG | Human | Yes | Prescription | 1 | ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) | 40 MG |
| Cancelled Post Market | 02048477 | ASTRAZENECA CANADA INC | NOLVADEX TAB 10MG | Human | Yes | Prescription | 1 | TAMOXIFEN (TAMOXIFEN CITRATE) | 10 MG |
| Cancelled Post Market | 02048485 | ASTRAZENECA CANADA INC | NOLVADEX-D TAB 20MG | Human | Yes | Prescription | 1 | TAMOXIFEN (TAMOXIFEN CITRATE) | 20 MG |
| Marketed | 02538539 | ASTRAZENECA CANADA INC | ONDEXXYA | Human | Yes | Schedule D | 1 | ANDEXANET ALFA | 200 MG / VIAL |
| Marketed | 02538539 | ASTRAZENECA CANADA INC | ONDEXXYA | Human | Yes | Prescription | 1 | ANDEXANET ALFA | 200 MG / VIAL |
| Marketed | 02333554 | ASTRAZENECA CANADA INC | ONGLYZA | Human | Yes | Prescription | 1 | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) | 5 MG |
| Marketed | 02375842 | ASTRAZENECA CANADA INC | ONGLYZA | Human | Yes | Prescription | 1 | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) | 2.5 MG |
| Marketed | 02237224 | ASTRAZENECA CANADA INC | OXEZE TURBUHALER | Human | Yes | Prescription | 1 | FORMOTEROL FUMARATE DIHYDRATE | 12 MCG / ACT |
| Marketed | 02237225 | ASTRAZENECA CANADA INC | OXEZE TURBUHALER | Human | Yes | Prescription | 1 | FORMOTEROL FUMARATE DIHYDRATE | 6 MCG / ACT |
| Cancelled Post Market | 00627127 | ASTRAZENECA CANADA INC | PENGLOBE TAB 400 MG | Human | No | Prescription | 1 | BACAMPICILLIN HYDROCHLORIDE | 400 MG |
| Cancelled Post Market | 00627135 | ASTRAZENECA CANADA INC | PENGLOBE TAB 800 MG | Human | No | Prescription | 1 | BACAMPICILLIN HYDROCHLORIDE | 800 MG / TAB |
| Cancelled Post Market | 00624756 | ASTRAZENECA CANADA INC | POTASSIUM CHLORIDE INJECTION 2MEQ/ML | Human | No | Ethical | 1 | POTASSIUM CHLORIDE | 2 mEq / ML |
| Marketed | 02229099 | ASTRAZENECA CANADA INC | PULMICORT NEBUAMP 0.125 MG/ML | Human | Yes | Prescription | 1 | BUDESONIDE | 0.125 MG / ML |
| Marketed | 01978918 | ASTRAZENECA CANADA INC | PULMICORT NEBUAMP 0.25 MG/ML | Human | Yes | Prescription | 1 | BUDESONIDE | 0.25 MG / ML |
| Marketed | 01978926 | ASTRAZENECA CANADA INC | PULMICORT NEBUAMP 0.5 MG/ML | Human | Yes | Prescription | 1 | BUDESONIDE | 0.5 MG / ML |
| Marketed | 00851752 | ASTRAZENECA CANADA INC | PULMICORT TURBUHALER | Human | Yes | Prescription | 1 | BUDESONIDE | 200 MCG / ACT |
| Marketed | 00851760 | ASTRAZENECA CANADA INC | PULMICORT TURBUHALER | Human | Yes | Prescription | 1 | BUDESONIDE | 400 MCG / ACT |
| Marketed | 00852074 | ASTRAZENECA CANADA INC | PULMICORT TURBUHALER | Human | Yes | Prescription | 1 | BUDESONIDE | 100 MCG / ACT |
| Cancelled Pre Market | 02459175 | ASTRAZENECA CANADA INC | QTERN | Human | Yes | Prescription | 2 | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) | 5 MG |
| Cancelled Pre Market | 02459183 | ASTRAZENECA CANADA INC | QTERN | Human | Yes | Prescription | 2 | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) | 5 MG |
| Cancelled Post Market | 02035324 | ASTRAZENECA CANADA INC | RHINOCORT TURBUHALER 100 MCG/DOSE | Human | Yes | Prescription | 1 | BUDESONIDE | 100 MCG / ACT |
| Cancelled Post Market | 02215616 | ASTRAZENECA CANADA INC | SALBUTAMOL NEBUAMP 0.05% | Human | No | Prescription | 1 | SALBUTAMOL (SALBUTAMOL SULFATE) | 0.05 % |
| Cancelled Post Market | 02215624 | ASTRAZENECA CANADA INC | SALBUTAMOL NEBUAMP 0.1% | Human | No | Prescription | 1 | SALBUTAMOL (SALBUTAMOL SULFATE) | 0.1 % |
| Cancelled Post Market | 02215632 | ASTRAZENECA CANADA INC | SALBUTAMOL NEBUAMP 0.2% | Human | No | Prescription | 1 | SALBUTAMOL (SALBUTAMOL SULFATE) | 0.2 % |
| Marketed | 02522845 | ASTRAZENECA CANADA INC | SAPHNELO | Human | Yes | Schedule D | 1 | ANIFROLUMAB | 150 MG / ML |
| Marketed | 02522845 | ASTRAZENECA CANADA INC | SAPHNELO | Human | Yes | Prescription | 1 | ANIFROLUMAB | 150 MG / ML |
| Marketed | 02236951 | ASTRAZENECA CANADA INC | SEROQUEL | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 25 MG |
| Marketed | 02236952 | ASTRAZENECA CANADA INC | SEROQUEL | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 100 MG |
| Marketed | 02236953 | ASTRAZENECA CANADA INC | SEROQUEL | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 200 MG |
| Cancelled Post Market | 02240862 | ASTRAZENECA CANADA INC | SEROQUEL | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 150 MG |
| Marketed | 02244107 | ASTRAZENECA CANADA INC | SEROQUEL | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 300 MG |
| Marketed | 02300184 | ASTRAZENECA CANADA INC | SEROQUEL XR | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 50 MG |
| Marketed | 02300192 | ASTRAZENECA CANADA INC | SEROQUEL XR | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 200 MG |
| Marketed | 02300206 | ASTRAZENECA CANADA INC | SEROQUEL XR | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 300 MG |
| Marketed | 02300214 | ASTRAZENECA CANADA INC | SEROQUEL XR | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 400 MG |
| Marketed | 02321513 | ASTRAZENECA CANADA INC | SEROQUEL XR | Human | Yes | Prescription | 1 | QUETIAPINE (QUETIAPINE FUMARATE) | 150 MG |
| Cancelled Post Market | 00701548 | ASTRAZENECA CANADA INC | SODIUM BICARBONATE INJECTION 75MG/ML | Human | No | Ethical | 1 | SODIUM BICARBONATE | 75 MG / ML |
| Cancelled Post Market | 00701572 | ASTRAZENECA CANADA INC | SODIUM BICARBONATE INJECTION 84MG/ML | Human | No | Ethical | 1 | SODIUM BICARBONATE | 84 MG / ML |
| Cancelled Post Market | 00624748 | ASTRAZENECA CANADA INC | SODIUM CHLORIDE INJECTION 0.9% | Human | No | Ethical | 1 | SODIUM CHLORIDE | 9 MG / ML |
| Cancelled Post Market | 00709611 | ASTRAZENECA CANADA INC | SODIUM CHLORIDE IRRIGATION SOLN 0.9% | Human | No | Ethical | 1 | SODIUM CHLORIDE | 9 MG / ML |
| Cancelled Post Market | 00624721 | ASTRAZENECA CANADA INC | STERILE WATER FOR INJECTION | Human | No | Ethical | 1 | WATER | null NIL / NIL |
| Marketed | 02245385 | ASTRAZENECA CANADA INC | SYMBICORT 100 TURBUHALER | Human | Yes | Prescription | 2 | BUDESONIDE | 100 MCG / ACT |
| Marketed | 02245386 | ASTRAZENECA CANADA INC | SYMBICORT 200 TURBUHALER | Human | Yes | Prescription | 2 | BUDESONIDE | 200 MCG / ACT |
| Approved | 02248218 | ASTRAZENECA CANADA INC | SYMBICORT FORTE TURBUHALER | Human | Yes | Prescription | 2 | FORMOTEROL FUMARATE DIHYDRATE | 12 MCG / ACT |
| Marketed | 02438364 | ASTRAZENECA CANADA INC | SYNAGIS | Human | Yes | Schedule D | 1 | PALIVIZUMAB | 100 MG / ML |
| Marketed | 02438364 | ASTRAZENECA CANADA INC | SYNAGIS | Human | Yes | Prescription | 1 | PALIVIZUMAB | 100 MG / ML |
| Marketed | 02438372 | ASTRAZENECA CANADA INC | SYNAGIS | Human | Yes | Prescription | 1 | PALIVIZUMAB | 50 MG / 0.5 ML |
| Marketed | 02438372 | ASTRAZENECA CANADA INC | SYNAGIS | Human | Yes | Schedule D | 1 | PALIVIZUMAB | 50 MG / 0.5 ML |
| Marketed | 02456214 | ASTRAZENECA CANADA INC | TAGRISSO | Human | Yes | Prescription | 1 | OSIMERTINIB (OSIMERTINIB MESYLATE) | 40 MG |
| Marketed | 02456222 | ASTRAZENECA CANADA INC | TAGRISSO | Human | Yes | Prescription | 1 | OSIMERTINIB (OSIMERTINIB MESYLATE) | 80 MG |
| Cancelled Post Market | 02049988 | ASTRAZENECA CANADA INC | TENORETIC 100/25MG TAB | Human | Yes | Prescription | 2 | ATENOLOL | 100 MG |
| Cancelled Post Market | 02049961 | ASTRAZENECA CANADA INC | TENORETIC 50/25MG TAB | Human | Yes | Prescription | 2 | ATENOLOL | 50 MG |
| Marketed | 02529548 | ASTRAZENECA CANADA INC | TEZSPIRE | Human | Yes | Prescription | 1 | TEZEPELUMAB | 110 MG / ML |
| Marketed | 02529548 | ASTRAZENECA CANADA INC | TEZSPIRE | Human | Yes | Schedule D | 1 | TEZEPELUMAB | 110 MG / ML |
| Marketed | 02529556 | ASTRAZENECA CANADA INC | TEZSPIRE | Human | Yes | Prescription | 1 | TEZEPELUMAB | 110 MG / ML |
| Marketed | 02529556 | ASTRAZENECA CANADA INC | TEZSPIRE | Human | Yes | Schedule D | 1 | TEZEPELUMAB | 110 MG / ML |
| Cancelled Post Market | 00460982 | ASTRAZENECA CANADA INC | THEO-DUR 100 MG | Human | No | Prescription | 1 | THEOPHYLLINE | 100 MG / SRT |
| Cancelled Post Market | 00460990 | ASTRAZENECA CANADA INC | THEO-DUR 200 MG | Human | No | Prescription | 1 | THEOPHYLLINE | 200 MG / SRT |
| Cancelled Post Market | 00461008 | ASTRAZENECA CANADA INC | THEO-DUR 300 MG | Human | No | Prescription | 1 | THEOPHYLLINE | 300 MG / SRT |
| Cancelled Post Market | 00722065 | ASTRAZENECA CANADA INC | THEO-DUR 450 MG | Human | No | Prescription | 1 | THEOPHYLLINE | 450 MG / SRT |
| Cancelled Post Market | 00598941 | ASTRAZENECA CANADA INC | TONOCARD TAB 400 MG | Human | No | Prescription | 1 | TOCAINIDE HYDROCHLORIDE | 400 MG |
| Marketed | 02544733 | ASTRAZENECA CANADA INC | TRUQAP | Human | Yes | Prescription | 1 | CAPIVASERTIB | 160 MG |
| Marketed | 02544741 | ASTRAZENECA CANADA INC | TRUQAP | Human | Yes | Prescription | 1 | CAPIVASERTIB | 200 MG |
| Cancelled Post Market | 02510847 | ASTRAZENECA CANADA INC | VAXZEVRIA | Human | Yes | Schedule D | 1 | CHADOX1-S [RECOMBINANT] | 50000000000 VP / 0.5 ML |
| Authorization By Interim Order Revoked | 02511444 | ASTRAZENECA CANADA INC | VAXZEVRIA | Human | Yes | COVID-19 - IO - Authorization | 1 | CHADOX1-S [RECOMBINANT] | 50000000000 VP / 0.5 ML |
| Authorization By Interim Order Revoked | 02511444 | ASTRAZENECA CANADA INC | VAXZEVRIA | Human | Yes | Schedule D | 1 | CHADOX1-S [RECOMBINANT] | 50000000000 VP / 0.5 ML |
| Approved | 02548909 | ASTRAZENECA CANADA INC | WAINUA | Human | Yes | Prescription Recommended | 1 | EPLONTERSEN (EPLONTERSEN SODIUM) | 45 MG / 0.8 ML |
| Marketed | 02449935 | ASTRAZENECA CANADA INC | XIGDUO | Human | Yes | Prescription | 2 | DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) | 5 MG |
| Marketed | 02449943 | ASTRAZENECA CANADA INC | XIGDUO | Human | Yes | Prescription | 2 | DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) | 5 MG |
| Cancelled Post Market | 00001724 | ASTRAZENECA CANADA INC | XYLOCAINE 0.5% | Human | Yes | Ethical | 1 | LIDOCAINE HYDROCHLORIDE | 5 MG / ML |
| Cancelled Post Market | 00001783 | ASTRAZENECA CANADA INC | XYLOCAINE 0.5% W EPINEPHRINE 1:100000 | Human | No | Ethical | 2 | LIDOCAINE HYDROCHLORIDE | 5 MG / ML |
| Cancelled Post Market | 00228915 | ASTRAZENECA CANADA INC | XYLOCAINE 0.5% W EPINEPHRINE 1:200000 | Human | No | Ethical | 2 | LIDOCAINE HYDROCHLORIDE | 5 MG / ML |
| Cancelled Post Market | 00001740 | ASTRAZENECA CANADA INC | XYLOCAINE 1.5% | Human | No | Ethical | 1 | LIDOCAINE HYDROCHLORIDE | 15 MG / ML |
| Cancelled Post Market | 00001813 | ASTRAZENECA CANADA INC | XYLOCAINE 1.5% W EPINEPHRINE 1:200000 | Human | Yes | Ethical | 2 | LIDOCAINE HYDROCHLORIDE | 15 MG / ML |
| Cancelled Post Market | 00753149 | ASTRAZENECA CANADA INC | XYLOCAINE 1.5% W EPINEPHRINE 1:200000 TEST DOSE | Human | Yes | Ethical | 2 | LIDOCAINE HYDROCHLORIDE | 15 MG / ML |
| Cancelled Post Market | 02229853 | ASTRAZENECA CANADA INC | XYLOCAINE 2% | Human | No | Ethical | 1 | LIDOCAINE HYDROCHLORIDE | 20 MG / ML |
| Cancelled Post Market | 00284122 | ASTRAZENECA CANADA INC | XYLOCAINE 2% EPIDURAL | Human | No | Ethical | 1 | LIDOCAINE HYDROCHLORIDE | 20 MG / ML |
| Cancelled Post Market | 00001821 | ASTRAZENECA CANADA INC | XYLOCAINE 2% W EPINEPHRINE 1:100000 | Human | Yes | Ethical | 2 | LIDOCAINE HYDROCHLORIDE | 20 MG / ML |
| Cancelled Post Market | 00613673 | ASTRAZENECA CANADA INC | XYLOCAINE 5% SPINAL | Human | No | Ethical | 1 | LIDOCAINE HYDROCHLORIDE | 50 MG / ML |
| Cancelled Post Market | 00276464 | ASTRAZENECA CANADA INC | XYLOCAINE CO2 INJ | Human | No | Ethical | 1 | LIDOCAINE | 17.3 MG / ML |
| Cancelled Post Market | 00049816 | ASTRAZENECA CANADA INC | XYLOCAINE TOPICAL 4% | Human | Yes | Ethical | 1 | LIDOCAINE HYDROCHLORIDE | 40 MG / ML |
| Cancelled Post Market | 00284114 | ASTRAZENECA CANADA INC | XYLOCAINE TOPICAL 5% | Human | No | Ethical | 1 | LIDOCAINE | 50 MG / ML |
Application information
Related information
Contact us
Version 4.0.2